DENVER, Dec. 16, 2021 /PRNewswire/ -- DaVita Integrated
Kidney Care (IKC) today announced its new clinical leadership
team, charged with reaching more patients through IKC programs and
further innovating care delivery across the kidney care continuum.
This team of experienced nephrologists is led by Dr. David Roer, DaVita IKC's newly appointed chief
medical officer (CMO). Dr. Roer previously served as DaVita's vice
president of medical affairs and national group medical
director.
Alongside Dr. Roer, the clinical leadership team consists of
Drs. Dorothy (Dody) Fisher, Unini
Odama, Michael O'Shea, and Amy
Schuerman-Gen. Together, this group will focus on improving the
care of patients with chronic kidney disease (CKD) and end stage
kidney disease in value-based partnerships that aim to help delay
disease progression, increase access to home dialysis and kidney
transplantation, and advance health equity at every step along the
kidney care journey.
"Through Dr. Roer's visionary leadership and commitment to
innovation, our IKC programs have helped to enhance the care and
quality of life for patients," said Dr. Jeff Giullian, CMO for DaVita Kidney Care. "This dynamic team brings
together the expertise to help more patients experience the
benefits of integrated care for years to come."
DaVita IKC currently manages more than 30,000 patients under
value-based care arrangements with commercial payors and through
government programs. Recently, the shift toward integrated kidney
care accelerated when the Center for Medicare & Medicaid
Services issued new payment models that aim to advance health
equity for kidney patients. As such, in 2022, DaVita is expecting
its IKC patient population could more than double in size.
"Integrated care should be the standard for how we treat
patients living with kidney disease," said Dr. Roer. "Each member
of the DaVita IKC clinical leadership team has played a vital role
in advancing this standard to better manage our patients' complex
health needs, and I'm looking forward to continuing this important
work together as we grow our programs."
DaVita IKC has more than two decades of experience taking care
of patients in value-based care programs. To learn more, please
visit DaVita.com/IKC.
About the DaVita IKC Clinical Leadership Team
Dr. David Roer, FACP, FAHA,
FASN, CMO for DaVita IKC, joined DaVita in 2018 as
the vice president of medical affairs for integrated kidney care.
Since 2020, he also served as DaVita's national group medical
director. Prior to joining DaVita, Dr. Roer was the managing
partner of Nephrology and Hypertension Associates for 30 years. He
has held leadership positions within several professional
nephrology organizations, most recently serving on the board of
directors at Renal Physician Association and as co-chair of the
Association for the Advancement of Medical Instrumentation Renal
Disease and Detoxification Committee. Dr. Roer completed his
medical training at Yale School of
Medicine, where he continues to serve as an associate
clinical professor of medicine.
Dr. Dorothy (Dody) Y. Fisher,
MGH, vice president of clinical education for DaVita IKC,
joined DaVita from Geisinger Health Plan, where she was the medical
director for provider network management, helping to build
strategic partner relationships to manage the transition to
value-based care. Prior to her time at DaVita, many of her roles
related to value-based care including leading Programs of
All-Inclusive Care for the Elderly (PACE) and clinically integrated networks. Dr.
Fisher received her medical degree and residency training from the
University of Vermont and her masters
in Geriatric Health Management from A.T. Still University.
Dr. Unini Odama, MPH, vice president of medical affairs for
DaVita IKC is a nephrologist and public health professional.
She completed her training in internal medicine at Michael Reese
Hospital/University of Illinois,
hypertension fellowship at RUSH-Presbyterian Medical Center in
Chicago, nephrology and
transplantation at the Medical College of
Virginia, clinical research at Harvard
University and public health at Emory
University. Prior to joining DaVita, Dr. Odama worked in
private practice settings in Alabama and Georgia. She also served as a district health
director for the Georgia Department of Health.
Dr. Michael O'Shea, vice
president of clinical leadership for DaVita IKC joined DaVita
in October 2021 after having served
as the medical director and vice president of ambulatory care
services at Dartmouth Hitchcock Health's Cheshire Medical Center in
Keene, NH. Dr. O'Shea has over 20
years of clinical nephrology experience focused on transplantation,
hypertension and slowing CKD progression. He is a graduate of the
University of Rochester School of
Medicine and completed his residency and fellowship training
at the University of Iowa and
Washington University in St. Louis.
Dr. Amy Schuerman-Gen, vice president of clinical operations
for DaVita IKC, oversees clinical operations for DaVita IKC's
government programs. She also helps streamline nurse practitioner
and care team workflows to further improve DaVita IKC's model of
care. Dr. Schuerman-Gen is passionate about value-based care and
serves as an industry thought leader on the transformation of
kidney care models. Dr. Schuerman-Gen received her medical degree
from Albany Medical College and
completed her internal medicine and nephrology fellowship at the
University of Colorado. Before joining
DaVita in 2020, she led a community nephrology practice in central
California and was the medical
director at a local outpatient dialysis and peritoneal dialysis
center.
About DaVita Integrated Kidney Care
DaVita Integrated
Kidney Care (DaVita IKC) is the integrated care division of
DaVita Kidney Care with programs
operating under the DaVita® and VillageHealth® brands for Total
Renal Care, Inc. and VillageHealth DM, LLC. DaVita IKC is the
country's largest kidney care provider accredited by
the National Committee for Quality Assurance (NCQA). It
provides comprehensive care and complex chronic condition
management to patients nationwide, whether they are in the early
stages of kidney disease, transitioning to end-stage
kidney disease, seeking a kidney transplant or receiving
life-sustaining dialysis. Over 100,000 lives have been impacted by
over 20 years of delivering integrated kidney care. Visit
DaVita.com/IKC for more information.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on
transforming care delivery to improve quality of life for patients
globally. The company is one of the largest providers of kidney
care services in the U.S. and has been a leader in clinical quality
and innovation for more than 20 years. DaVita cares for patients at
every stage and setting along their kidney health journey—from
slowing the progression of kidney disease to helping to support
transplantation, from acute hospital care to dialysis at home. As
of September 30, 2021, DaVita served 203,000 patients at 2,822
outpatient dialysis centers in the United States. The company also operated 333
outpatient dialysis centers in ten countries worldwide. DaVita has
reduced hospitalizations, improved mortality, and worked
collaboratively to propel the kidney care industry to adopt an
equitable and high-quality standard of care for all patients,
everywhere. To learn more, visit DaVita.com/About.
Forward-Looking Statements
Certain
statements in this press release are forward-looking statements
that are subject to risks and uncertainties. These forward-looking
statements are based on management's current expectations. Various
important factors could cause actual results to differ materially
from these forward-looking statements, including the risks
identified in our U.S. Securities and Exchange Commission filings.
DaVita disclaims any obligation to update any forward-looking
statement contained in this press release, except as may be
otherwise required by law.
Contact:
Halie Peddle
303-550-6349
Halie.Peddle@DaVita.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/davita-integrated-kidney-care-expands-clinical-leadership-team-301446091.html
SOURCE DaVita IKC